Alfred Altomari - 13 May 2024 Form 4 Insider Report for INSMED Inc (INSM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 May 2024, 16:14:44 UTC
Prior SEC filing
30 Jun 2023
Next SEC filing
26 Aug 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Alfred Altomari, by Michael A. Smith as Attorney-in-fact

Key filing fact

Alfred Altomari filed Form 4 for INSMED Inc (INSM) on 15 May 2024.

Key facts

  • This page summarizes Alfred Altomari's Form 4 filing for INSMED Inc (INSM).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 15 May 2024, 16:14.

Change

  • Previous filing in this sequence was filed on 30 Jun 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INSM transaction

Common Stock

Award

Transaction value
Shares
+13,162
Change %
+23%
Price
Shares after
69,495
Date
13 May 2024
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs have a one year cliff vesting period, provided that the director (a) remains a member of the Board of Directors of the issuer on such vesting date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date.

Footnote F2

Each RSU was granted on May 13, 2024 for no consideration.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .